По вашему запросу найдено документов: 130

Страница 1 из 13

SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERY
LEGG, L.A., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M.A., DENNIS, M., MEAD, G.E., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J (2019)
Trials Register (last searched 16 July 2018), the Cochrane Controlled Trials Register (CENTRAL, Issue 7
FLUOXETINE FOR STROKE RECOVERY META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
MEAD, G.E., LEGG, L., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M., DENNIS, M.S., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J. (2020)
). There was no difference in the proportion independent (3 trials, n = 3249, 36.6% fluoxetine vs. 36.7% control; RR 1.00, 95
EFFICACY AND SAFETY OF INSULIN GLARGINE 300 UNITS/ML (GLA-300) VERSUS INSULIN GLARGINE 100 UNITS/ML (GLA-100) IN CHILDREN AND ADOLESCENTS (6-17 YEARS) WITH TYPE 1 DIABETES: RESULTS OF THE EDITION JUNIOR RANDOMIZED CONTROLLED TRIAL
DANNE, T., TAMBORLANE, W.V., MALIEVSKY, O.A., FRANCO, D.R., KAWAMURA, T., DEMISSIE, M., NIEMOELLER, E., GOYEAU, H., WARDECKI, M., BATTELINO, T. (2020)
trial. Participants were randomized 1:1 to Gla-300 or Gla-100, titrated to achieve fasting self
Therapeutic drug monitoring (TDM) as intervention: A cross-sectional analysis of characteristics of 173 registered clinical trials
Zhao, Shanshan, Zaytseva, Olga, Zaytseva, Olga, Zhang, Boquan (2022)
-quality large-scale, multicenter randomized clinical trials (RCTs) are designed and implemented to promote
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Lomakin, NV, Bakirov, BA, Protsenko, DN, Mazurov, VI, Musaev, GH, Moiseeva, OM, Pasechnik, ES, Popov, VV, Smolyarchuk, EA, Gordeev, IG, Gilyarov, MY, Fomina, DS, Seleznev, AI, Linkova, YN, Dokukina, EA, Eremeeva, AV, Pukhtinskaia, PS, Morozova, MA, Zinkina-Orikhan, AV, Lutckii, AA (2021)
Objective and design The aim of this double-blind, placebo-controlled, phase III CORONA clinical
Применение препарата, содержащего технологически обработанные антитела к каннабиноидному рецептору 1-го типа, для лечения ожирения у взрослых: результаты многоцентрового двойного слепого плацебо-контролируемого рандомизированного клинического исследования
The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial
Demidova, TY, Krasil'nikova, EI, Vorob'ev, SV, Morugova, TV, Adasheva, TV, Демидова, Т.Ю., Красильникова, Е.И., Воробьев, С.В., Моругова, Т.В., Адашева, Т.В. (2021)
in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
Alexeeva, E, Horneff, G., Dvoryakovskaya, T., Denisova, R., Nikishina, I., Zholobova, E., Malievskiy, V., Santalova, G., Stadler, E., Balykova, L., Spivakovskiy, Y., Kriulin, I., Alshevskaya, A., Moskalev, A. (2021)
-centre, double-blind, randomized study in active polyarticular JIA patients treated with either ETA+MTX (n = 35
B-CURE LASER DENTAL PRO TECHNOLOGY FOR PREVENTION AND TREATMENT OF PERI-IMPLANT MUCOSITIS
Gileva, O.S., Libik, T.V., Chuprakov, M.A., Yakov, A.Y., Mirsaeva, F.Z. (2017)
blind randomized prospective one-center comparative placebo-controlled clinical trial is carried out
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
: A multicenter, open-label, randomized, controlled phase 2 study in children with GHD, evaluating
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T, De Souza Viana, L., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J.G., Psyrri, A., Vasilevskaya, I., Nangia, C.S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J.M., Asarawala, N., Nicolau, U.R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E.E.W. (2019)
. Design, Setting, and Participants: This multicenter, phase 3, double-blind randomized clinical trial (LUX

Страница 1 из 13

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год